212 related articles for article (PubMed ID: 21489086)
1. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
Zhang L; Zhang L; Lu Y; Wu B; Zhang S; Jiang H; Ge J; Chen H
Int J Clin Pract; 2011 May; 65(5):624-30. PubMed ID: 21489086
[TBL] [Abstract][Full Text] [Related]
2. Renal replacement therapy for prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.
Song K; Jiang S; Shi Y; Shen H; Shi X; Jing D
Am J Nephrol; 2010; 32(5):497-504. PubMed ID: 20975263
[TBL] [Abstract][Full Text] [Related]
3. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
[TBL] [Abstract][Full Text] [Related]
5. Effect of statins in preventing contrast-induced nephropathy: an updated meta-analysis.
Xie H; Ye Y; Shan G; Zhang S; Fang Q; Yang D; Zeng Y
Coron Artery Dis; 2014 Nov; 25(7):565-74. PubMed ID: 25036858
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of statin therapy in adults with coronary heart disease.
Wilt TJ; Bloomfield HE; MacDonald R; Nelson D; Rutks I; Ho M; Larsen G; McCall A; Pineros S; Sales A
Arch Intern Med; 2004 Jul; 164(13):1427-36. PubMed ID: 15249352
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials.
Li Y; Liu Y; Fu L; Mei C; Dai B
PLoS One; 2012; 7(4):e34450. PubMed ID: 22511942
[TBL] [Abstract][Full Text] [Related]
8. Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry.
Hoshi T; Sato A; Kakefuda Y; Harunari T; Watabe H; Ojima E; Hiraya D; Abe D; Nishina H; Takeyasu N; Noguchi Y; Aonuma K
Int J Cardiol; 2014 Feb; 171(2):243-9. PubMed ID: 24393575
[TBL] [Abstract][Full Text] [Related]
9. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions.
Khanal S; Attallah N; Smith DE; Kline-Rogers E; Share D; O'Donnell MJ; Moscucci M
Am J Med; 2005 Aug; 118(8):843-9. PubMed ID: 16084176
[TBL] [Abstract][Full Text] [Related]
10. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.
Li H; Wang C; Liu C; Li R; Zou M; Cheng G
Am J Cardiovasc Drugs; 2016 Jun; 16(3):201-19. PubMed ID: 26899537
[TBL] [Abstract][Full Text] [Related]
12. Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.
Dai B; Liu Y; Fu L; Li Y; Zhang J; Mei C
Am J Kidney Dis; 2012 Sep; 60(3):360-70. PubMed ID: 22516682
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
Zagler A; Azadpour M; Mercado C; Hennekens CH
Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization.
Giacoppo D; Capodanno D; Capranzano P; Aruta P; Tamburino C
Am J Cardiol; 2014 Aug; 114(4):541-8. PubMed ID: 25001154
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes.
Marenzi G; Cosentino N; Werba JP; Tedesco CC; Veglia F; Bartorelli AL
Int J Cardiol; 2015 Mar; 183():47-53. PubMed ID: 25662053
[TBL] [Abstract][Full Text] [Related]
18. High-dose statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis.
Zhang BC; Li WM; Xu YW
Can J Cardiol; 2011; 27(6):851-8. PubMed ID: 21944277
[TBL] [Abstract][Full Text] [Related]
19. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
[TBL] [Abstract][Full Text] [Related]
20. Impact of statins on risk of stroke: a meta-analysis.
Henyan NN; Riche DM; East HE; Gann PN
Ann Pharmacother; 2007 Dec; 41(12):1937-45. PubMed ID: 17986516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
